Sun Pharmaceuticals reported INR30.07B in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aspen Pharmacare APN:SJ ZAR 4.58B 1.07B
Bharat Petroleum BPCL:IN INR 42.13B 27.98B
Cipla CIPLA:IN INR 14.08B 1.05B
Dr.Reddys Laboratories DRRD:IN INR 19.52B 505M
Reliance Infra RELI:IN INR 352.47B 40.23B
Sun Pharmaceuticals SUNP:IN INR 30.07B 1.91B
UPL UPLL:IN INR 30.34B 2.66B